Withdrawal of Infliximab Therapy in Ankylosing Spondylitis in Persistent Clinical Remission, Results From the REMINEA Study

Arthritis Research & Therapy
doi 10.1186/s13075-019-1873-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

From Rehabilitation to Remission in Ankylosing Spondylitis

Reumatismo
Rheumatology
2011English

Management of Ankylosing Spondylitis With Infliximab

Open Access Rheumatology: Research and Reviews
Rheumatology
2009English

Polyarthritis Flare in Patient With Ankylosing Spondylitis Treated With Infliximab

Reumatismo
Rheumatology
2011English

Symptomatic Therapy for Ankylosing Spondylitis

Modern Rheumatology Journal
2012English

Unmet Needs in Ankylosing Spondylitis Patients Receiving Tumour Necrosis Factor Inhibitor Therapy; Results From a Large Multinational Real-World Study

BMC Rheumatology
Rheumatology
2020English

Comparative Evaluation of the Long-Term Efficacy and Safety of the Infliximab Biosimilar BCD-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-Blind Phase Iii Clinical Study Asart-2

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Effects of Etanercept and Infliximab on Bone Metabolism Indexes in Patients With Ankylosing Spondylitis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Sulphasalazine in Ankylosing Spondylitis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy